Atlas Legacy Advisors LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CL – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 3,420 shares of the company’s stock, valued at approximately $311,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive in the fourth quarter worth approximately $32,000. Hager Investment Management Services LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth approximately $36,000. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive in the third quarter worth approximately $42,000. Roxbury Financial LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth approximately $43,000. Finally, Synergy Asset Management LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth approximately $49,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have recently commented on the company. Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $101.16.
Colgate-Palmolive Trading Up 1.1 %
NYSE CL opened at $87.32 on Thursday. Colgate-Palmolive has a 1-year low of $83.70 and a 1-year high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a market capitalization of $70.86 billion, a PE ratio of 24.81, a price-to-earnings-growth ratio of 4.10 and a beta of 0.44. The firm’s fifty day simple moving average is $89.13 and its 200-day simple moving average is $96.05.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm earned $0.87 EPS. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.76 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Consumer Staples Stocks, Explained
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is the S&P/TSX Index?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Using the MarketBeat Dividend Yield Calculator
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.